Galanin Regulates Myocardial Mitochondrial ROS Homeostasis and Hypertrophic Remodeling Through GalR2

Area of Science:

• Cardiovascular Biology
• Neuroendocrinology
• Molecular Medicine

Background:

• Galanin is a regulatory peptide with broad physiological roles.
• The galaninergic system's function in the heart is not well understood.
• Galanin exerts effects via G-protein-coupled receptors (GalR1-3).

Purpose of the Study:

• To investigate galanin receptor expression in cardiac cells and tissues.
• To determine the role of galanin and its receptors in cardiac function and disease.
• To identify the primary galanin receptor subtype in the adult mouse heart.

Main Methods:

• Quantitative analysis of galanin receptor expression in mouse hearts, cardiomyocytes, and H9C2 cardiomyoblasts.
• In vivo studies using genetic suppression of GalR2.
• In vitro studies involving GalR2 silencing via siRNA and galanin treatment.

Main Results:

• GalR2 was identified as the dominant galanin receptor subtype in adult mouse hearts and cardiac cells.
• In vivo genetic suppression of GalR2 led to cardiac hypertrophy, fibrosis, and mitochondrial oxidative stress.
• In vitro GalR2 silencing negated galanin's protective effects against cell hypertrophy and ROS production.

Conclusions:

• Galanin receptor 2 plays a significant role in maintaining cardiac homeostasis.
• The galaninergic system, particularly GalR2, represents a potential therapeutic target for heart disease.
• Findings provide novel insights into the galaninergic system's function in the cardiovascular system.